As of Dec 15
| 0.00 / 0.00%|
The 8 analysts offering 12-month price forecasts for Bellicum Pharmaceuticals Inc have a median target of 25.00, with a high estimate of 32.00 and a low estimate of 16.00. The median estimate represents a +194.46% increase from the last price of 8.49.
The current consensus among 8 polled investment analysts is to Buy stock in Bellicum Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.